Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Fenretinide (4HPR) Inhibits Growth of Myeloma Cells in Their Microenvironment and Is a Potent Inhibitor of Angiogenesis and Osteoclastogenesis.

Xin Li, PhD, Wen Ling, Rinku Saha, Paul Perkins, Angela Pennisi, Shmuel Yaccoby, Ph.D.

Blood (2006) 108 (11): 3480.

https://doi.org/10.1182/blood.V108.11.3480.3480

Published: 2006

Journal Articles

Atacicept (TACI-Ig) Inhibits Growth of TACI high Primary Myeloma Cells in SCID-Hu Mice.

Shmuel Yaccoby, PhD, Stacey R. Dillon, PhD, Wen Ling, Paul Perkins, John R. Tisdale, Angela Pennisi, MD, Rinku Saha, Xin Li, PhD, Bart Barlogie, MD, PhD, Guido Tricot, MD, Fenghuang Zhan, MD, PhD, John Shaughnessy, PhD

Blood (2006) 108 (11): 842.

https://doi.org/10.1182/blood.V108.11.842.842

Published: 2006

Journal Articles

PTH and Bortezomib Suppress Growth of Primary Human Myeloma through Increased Bone Formation In Vivo.

Angela Pennisi, MD, Wen Ling, Paul Perkins, Rinku Saha, Xin Li, Bart Barlogie, MD, PhD, Guido Tricot, MD, Maurizio Zangari, MD, Shmuel Yaccoby, PhD

Blood (2006) 108 (11): 509.

https://doi.org/10.1182/blood.V108.11.509.509

Published: 2006

Journal Articles

Anti-Myeloma Response to Bortezomib Is Associated with Increased Osteoblast Activity and Bone Formation in Primary Myelomatous SCID-rab Mice.

Shmuel Yaccoby, PhD, Wen Ling, Rinku Saha, Bart Barlogie, MD, PhD, Guido Tricot, MD, Maurizio Zangari, MD

Blood (2005) 106 (11): 3450.

https://doi.org/10.1182/blood.V106.11.3450.3450

Published: 2005

Journal Articles

Systemic Treatment with the Antiangiogenic Agent ABT-510 Inhibited Myeloma-Induced Microvessels and Tumor Growth in Myelomatous SCID-hu Mice.

Shmuel Yaccoby, PhD, Wen Ling, Rinku Saha, Kenichiro Yata, MD, Guido Tricot, MD

Blood (2005) 106 (11): 3451.

https://doi.org/10.1182/blood.V106.11.3451.3451

Published: 2005

Journal Articles

Inhibition of DKK1 Activity Is Associated with Increased Osteoblast Numbers and Bone Formation, Reduced Osteoclast Activity and Inhibition of Tumor Growth in the SCID-rab Model for Primary Myeloma.

Shmuel Yaccoby, PhD, Wen Ling, Rinku Saha, Fenghuang Zhan, MD, PhD, Ron Walker, MD, Guido Tricot, MD, Bart Barlogie, MD, PhD, John D. Shaughnessy, Jr., PhD

Blood (2005) 106 (11): 638.

https://doi.org/10.1182/blood.V106.11.638.638

Published: 2005

Journal Articles

Myeloma Cells Cultivate Megakaryocytes To Promote Lytic Bone Disease.

Shmuel Yaccoby, PhD, Rinku Saha, Ewa Kozlowska, Yun Ge, PhD, Wen Ling, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Guido Tricot, MD

Blood (2005) 106 (11): 2495.

https://doi.org/10.1182/blood.V106.11.2495.2495

Published: 2005

Journal Articles

Reciprocal Interaction between Megakaryocytes and Myeloma Cells Results in Increased Survival and Proliferation of Myeloma Cells.

Shmuel Yaccoby, PhD, Rinku Saha, Ewa Kozlowska, Yun Ge, PhD, Wen Ling, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Guido Tricot, MD

Blood (2005) 106 (11): 628.

https://doi.org/10.1182/blood.V106.11.628.628

Published: 2005

NARROW

Fenretinide (4HPR) Inhibits Growth of Myeloma Cells in Their Microenvironment and Is a Potent Inhibitor of Angiogenesis and Osteoclastogenesis.

Atacicept (TACI-Ig) Inhibits Growth of TACI high Primary Myeloma Cells in SCID-Hu Mice.

PTH and Bortezomib Suppress Growth of Primary Human Myeloma through Increased Bone Formation In Vivo.

Anti-Myeloma Response to Bortezomib Is Associated with Increased Osteoblast Activity and Bone Formation in Primary Myelomatous SCID-rab Mice.

Systemic Treatment with the Antiangiogenic Agent ABT-510 Inhibited Myeloma-Induced Microvessels and Tumor Growth in Myelomatous SCID-hu Mice.

Inhibition of DKK1 Activity Is Associated with Increased Osteoblast Numbers and Bone Formation, Reduced Osteoclast Activity and Inhibition of Tumor Growth in the SCID-rab Model for Primary Myeloma.

Myeloma Cells Cultivate Megakaryocytes To Promote Lytic Bone Disease.

Reciprocal Interaction between Megakaryocytes and Myeloma Cells Results in Increased Survival and Proliferation of Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only